The Russian Foreign Ministry condemned the United States for providing Ukraine with the proceeds from Russia's frozen assets and announced retaliatory measures. The Russian Foreign Ministry issued a statement on the 11th local time, condemning the United States for providing Ukraine with a loan of $20 billion with the proceeds from frozen Russian assets as collateral, calling this behavior "theft". According to a report quoted by Russian Tass news agency from Russian Ministry of Finance, in retaliation, Russia will use the proceeds from the frozen assets of western countries in Russia to support Russia's regional and economic development.Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.
The project of Chuangpu Instrument Industrial Park started in Hefei, with a total investment of 320 million yuan. According to the news of Hefei High-tech Zone Management Committee, on December 10th, the project of Chuangpu Instrument Industrial Park at the intersection of Caihong West Road and Peacock Terrace Road in Hefei High-tech Zone officially started. The total investment of the project is 320 million yuan, which is planned to be completed at one time and is expected to be put into use in the second half of 2027.Meitu, a Hong Kong stock company, rose more than 10% in intraday trading, with turnover exceeding HK$ 400 million.FTSE China A50 index futures rose 1%.
Malaysia established the National Office of Artificial Intelligence Policies and Regulations.The liquor sector moved up, Tianyoude Liquor rose daily, Gujing Distillery rose by more than 4%, and Huangtai Liquor, Shunxin Agriculture, Laobaigan Liquor and Yilite followed suit.The total investment scale of Haiyouwei's factory in the United States may reach 10 million US dollars. According to Haiyouwei Science and Technology, on December 11th, Haiyouwei announced that it planned to set up a subsidiary in the United States to implement the polymer special membrane project. This project is a deepening cooperation between Haiyouwei and its industry partners on the basis of strategic and technical cooperation in the United States. It is an important measure to achieve the localized production and market-oriented extension of the company's photovoltaic packaging film in the American market. It is estimated that the total investment will not exceed 10 million US dollars.
Strategy guide
12-13
Strategy guide 12-13